Grants per year
Personal profile
Research Interests
Personalized Cancer Therapy, Precision Medicine, Early Phase Clinical Trials, First-in-Human Study, Novel Combination Cancer Therapy, Targeted therapy, Immunotherapy, Biomarker Study, Novel Drug Development, Novel Drug Delivery System, Adaptive Clinical Trials Design, Cell Signaling Pathway, Immune Checkpoint Pathway
Training Experience
| 2011 | Residency, Albert Einstein Medical Center |
| 2014 | Fellowship, University of Texas/MD Anderson Cancer Center |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
MBA, Medical Management, Johns Hopkins University
… → 2007
MPH, Public Health, Johns Hopkins University
… → 2007
MD, Medicine, Seoul National University
… → 2002
Research interests keywords
- Oncology
Fingerprint
Dive into the research topics where Young Kwang Chae is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Prot #1454‐0001: A First‐in‐Human Phase I, Non‐Randomized, Open‐Label, Multicenter Dose Escalation Trial of BI 765049 and BI 765049 + Ezabenlimab (BI 754091) Administered by Repeated Intravenous Infusions in Patients with Malignant Solid Tumors Expressi
SCRI Development Innovations, LLC, Boehringer Ingelheim Pharmaceuticals, Inc.
11/10/23 → 11/10/26
Project: Research project
-
The distinct role of cysteinyl leukotriene receptor for myeloid-derived suppressive cells
Zhang, B., Zhang, B., Chae, Y. K., Chae, Y. K., Fang, D., Fang, D., Sosman, J. A., Sosman, J. A., Zou, L. & Zou, L.
5/15/20 → 4/30/26
Project: Research project
-
A Comprehensive Landscape of De Novo Malignancy After Double Lung Transplantation
Lee, J., Yang, A. W. J., Chung, L. I. Y., Yu, J., Lee, Y., Kim, H. S., Shin, H. J., Choi, Y. G., Bharat, A. & Chae, Y. K., 2023, In: Transplant International. 36, 11552.Research output: Contribution to journal › Article › peer-review
Open Access -
Current and future role of double-lung transplantation for bilateral lung cancer
Lee, J., Schellenberg, S. J., Chung, L. I. Y., Bharat, A. & Chae, Y. K., Jul 2023, In: Transplantation Reviews. 37, 3, 100772.Research output: Contribution to journal › Review article › peer-review
Open Access -
Cushing's Syndrome in Adenocarcinoma of Lung Responding to Osilodrostat
Heleno, C. T., Hong, S. P. D., Cho, H. G., Kim, M. J., Park, Y. & Chae, Y. K., 2023, (Accepted/In press) In: Case Reports in Oncology. p. 124-128 5 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Papillary thyroid cancer immune phenotypes via tumor-infiltrating lymphocyte spatial analysis
Nam, M., Yang, W., Kim, H. S., Park, J., Park, G., Kim, S., Song, S., Ock, C. Y., Wang, V. G., Chuang, J. H. & Chae, Y. K., Sep 1 2023, In: Endocrine-related cancer. 30, 9Research output: Contribution to journal › Article › peer-review
-
Phase I study of anti-epidermal growth factor receptor antibody-drug conjugate serclutamab talirine: Safety, pharmacokinetics, and antitumor activity in advanced glioblastoma
Carneiro, B. A., Papadopoulos, K. P., Strickler, J. H., Lassman, A. B., Waqar, S. N., Chae, Y. K., Patel, J. D., Shacham-Shmueli, E., Kelly, K., Khasraw, M., Bestvina, C. M., Merrell, R., Huang, K., Atluri, H., Ansell, P., Li, R., Jin, J., Anderson, M. G., Reilly, E. B., Morrison-Thiele, G., & 4 others, Jan 1 2023, In: Neuro-Oncology Advances. 5, 1, vdac183.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations
Datasets
-
-
Exceptional response to chemotherapy followed by concurrent radiotherapy and immunotherapy in a male with primary retroperitoneal serous Adenocarcinoma: a case report and literature review
Chae, Y. K. (Creator), Saleem, N. (Creator), Roh, Y. (Contributor), Bilal, H. (Creator), Viveiros, P. (Creator), Sukhadia, B. (Contributor), Lin, X. (Contributor), Sheikh, M. M. (Creator) & Park, L. C. (Creator), figshare, 2019
DOI: 10.6084/m9.figshare.c.4601576, https://springernature.figshare.com/collections/Exceptional_response_to_chemotherapy_followed_by_concurrent_radiotherapy_and_immunotherapy_in_a_male_with_primary_retroperitoneal_serous_Adenocarcinoma_a_case_report_and_literature_review/4601576
Dataset
-
Supplementary Material for: Cushing’s Syndrome in Adenocarcinoma of Lung Responding to Osilodrostat
Heleno, C. T. (Contributor), Hong, S. P. D. (Contributor), Cho, H. (Contributor), Kim, M. J. (Contributor), Park, Y. (Contributor) & Chae, Y. K. (Contributor), Karger Publishers, 2023
DOI: 10.6084/m9.figshare.22146836.v1, https://karger.figshare.com/articles/dataset/Supplementary_Material_for_Cushing_s_Syndrome_in_Adenocarcinoma_of_Lung_Responding_to_Osilodrostat/22146836/1
Dataset